T. Rowe Price Reports 8.1% Stake in Descartes
T. Rowe Price Associates, Inc., a Maryland-based investment adviser, filed an amended Schedule 13G reporting beneficial ownership of 6,993,172 shares of Descartes Systems common stock, representing 8.1% of the class as of the event date of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc., a Maryland-based investment adviser, filed an amended Schedule 13G reporting beneficial ownership of 6,993,172 shares of Descartes Systems common stock, representing 8.1% of the class as of the event date of 12/31/2025.
The firm reports sole power to vote 7,514,534 shares and sole power to dispose of 7,725,466 shares, with no shared voting or dispositive power. It states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Descartes Systems.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership did T. Rowe Price report in its Schedule 13G/A for DSGX?
How much of Descartes Systems’ stock, in percentage terms, does T. Rowe Price hold?
Who is the reporting person in the Descartes Systems Schedule 13G/A filing?
What is the event date for T. Rowe Price’s reported ownership in DSGX?
AI-generated analysis. How Rhea-AI works. Not financial advice.